# Dexmedetomidine in Seizure Patients

> **NCT01116700** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 16 (actual)

## Conditions studied

- Seizure Disorders

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT01116700
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2013-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01116700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01116700, "Dexmedetomidine in Seizure Patients". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT01116700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*